269 related articles for article (PubMed ID: 24503136)
1. The Pex1-G844D mouse: a model for mild human Zellweger spectrum disorder.
Hiebler S; Masuda T; Hacia JG; Moser AB; Faust PL; Liu A; Chowdhury N; Huang N; Lauer A; Bennett J; Watkins PA; Zack DJ; Braverman NE; Raymond GV; Steinberg SJ
Mol Genet Metab; 2014 Apr; 111(4):522-532. PubMed ID: 24503136
[TBL] [Abstract][Full Text] [Related]
2. Liver disease predominates in a mouse model for mild human Zellweger spectrum disorder.
Berendse K; Boek M; Gijbels M; Van der Wel NN; Klouwer FC; van den Bergh-Weerman MA; Shinde AB; Ofman R; Poll-The BT; Houten SM; Baes M; Wanders RJA; Waterham HR
Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2774-2787. PubMed ID: 31207289
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal study of Pex1-G844D NMRI mouse model: A robust pre-clinical model for mild Zellweger spectrum disorder.
Demaret T; Roumain M; Ambroise J; Evraerts J; Ravau J; Bouzin C; Bearzatto B; Gala JL; Stepman H; Marie S; Vincent MF; Muccioli GG; Najimi M; Sokal EM
Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165900. PubMed ID: 32693164
[TBL] [Abstract][Full Text] [Related]
4. A longitudinal study of retinopathy in the PEX1-Gly844Asp mouse model for mild Zellweger Spectrum Disorder.
Argyriou C; Polosa A; Cecyre B; Hsieh M; Di Pietro E; Cui W; Bouchard JF; Lachapelle P; Braverman N
Exp Eye Res; 2019 Sep; 186():107713. PubMed ID: 31254513
[TBL] [Abstract][Full Text] [Related]
5. Zellweger spectrum disorder patient-derived fibroblasts with the PEX1-Gly843Asp allele recover peroxisome functions in response to flavonoids.
MacLean GE; Argyriou C; Di Pietro E; Sun X; Birjandian S; Saberian P; Hacia JG; Braverman NE
J Cell Biochem; 2019 Mar; 120(3):3243-3258. PubMed ID: 30362618
[TBL] [Abstract][Full Text] [Related]
6. High Dose Versus Low Dose Syngeneic Hepatocyte Transplantation in
Demaret T; Evraerts J; Ravau J; Roumain M; Muccioli GG; Najimi M; Sokal EM
Cells; 2020 Dec; 10(1):. PubMed ID: 33396635
[TBL] [Abstract][Full Text] [Related]
7. Disorders of peroxisome biogenesis due to mutations in PEX1: phenotypes and PEX1 protein levels.
Walter C; Gootjes J; Mooijer PA; Portsteffen H; Klein C; Waterham HR; Barth PG; Epplen JT; Kunau WH; Wanders RJ; Dodt G
Am J Hum Genet; 2001 Jul; 69(1):35-48. PubMed ID: 11389485
[TBL] [Abstract][Full Text] [Related]
8. Novel PEX1 mutations in fibroblasts from children with Zellweger spectrum disorders exhibit temperature sensitive characteristics.
Liang JS; Hung KL; Lin LJ; Ong WP; Keng WT; Lu JF
Epilepsy Behav; 2023 Aug; 145():109266. PubMed ID: 37385119
[TBL] [Abstract][Full Text] [Related]
9. A common PEX1 frameshift mutation in patients with disorders of peroxisome biogenesis correlates with the severe Zellweger syndrome phenotype.
Maxwell MA; Nelson PV; Chin SJ; Paton BC; Carey WF; Crane DI
Hum Genet; 1999; 105(1-2):38-44. PubMed ID: 10480353
[TBL] [Abstract][Full Text] [Related]
10. Mild Zellweger syndrome due to functionally confirmed novel PEX1 variants.
Lipiński P; Stawiński P; Rydzanicz M; Wypchło M; Płoski R; Stradomska TJ; Jurkiewicz E; Ferdinandusse S; Wanders RJA; Vaz FM; Tylki-Szymańska A
J Appl Genet; 2020 Feb; 61(1):87-91. PubMed ID: 31628608
[TBL] [Abstract][Full Text] [Related]
11. Recovery of PEX1-Gly843Asp peroxisome dysfunction by small-molecule compounds.
Zhang R; Chen L; Jiralerspong S; Snowden A; Steinberg S; Braverman N
Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5569-74. PubMed ID: 20212125
[TBL] [Abstract][Full Text] [Related]
12. Induced pluripotent stem cell models of Zellweger spectrum disorder show impaired peroxisome assembly and cell type-specific lipid abnormalities.
Wang XM; Yik WY; Zhang P; Lu W; Huang N; Kim BR; Shibata D; Zitting M; Chow RH; Moser AB; Steinberg SJ; Hacia JG
Stem Cell Res Ther; 2015 Aug; 6():158. PubMed ID: 26319495
[TBL] [Abstract][Full Text] [Related]
13. Phenotype-genotype relationships in peroxisome biogenesis disorders of PEX1-defective complementation group 1 are defined by Pex1p-Pex6p interaction.
Tamura S; Matsumoto N; Imamura A; Shimozawa N; Suzuki Y; Kondo N; Fujiki Y
Biochem J; 2001 Jul; 357(Pt 2):417-26. PubMed ID: 11439091
[TBL] [Abstract][Full Text] [Related]
14. Spectrum of PEX1 and PEX6 variants in Heimler syndrome.
Smith CE; Poulter JA; Levin AV; Capasso JE; Price S; Ben-Yosef T; Sharony R; Newman WG; Shore RC; Brookes SJ; Mighell AJ; Inglehearn CF
Eur J Hum Genet; 2016 Nov; 24(11):1565-1571. PubMed ID: 27302843
[TBL] [Abstract][Full Text] [Related]
15. Disruption of a PEX1-PEX6 interaction is the most common cause of the neurologic disorders Zellweger syndrome, neonatal adrenoleukodystrophy, and infantile Refsum disease.
Geisbrecht BV; Collins CS; Reuber BE; Gould SJ
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8630-5. PubMed ID: 9671729
[TBL] [Abstract][Full Text] [Related]
16. Genetic and clinical aspects of Zellweger spectrum patients with PEX1 mutations.
Rosewich H; Ohlenbusch A; Gärtner J
J Med Genet; 2005 Sep; 42(9):e58. PubMed ID: 16141001
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome biogenesis disorders with prolonged survival: phenotypic expression in a cohort of 31 patients.
Poll-The BT; Gootjes J; Duran M; De Klerk JB; Wenniger-Prick LJ; Admiraal RJ; Waterham HR; Wanders RJ; Barth PG
Am J Med Genet A; 2004 May; 126A(4):333-8. PubMed ID: 15098231
[TBL] [Abstract][Full Text] [Related]
18. Two different missense mutations of PEX genes in two similar patients with severe Zellweger syndrome: an argument on the genotype-phenotype correlation.
Havali C; Dorum S; Akbaş Y; Görükmez O; Hirfanoglu T
J Pediatr Endocrinol Metab; 2020 Mar; 33(3):437-441. PubMed ID: 32069232
[TBL] [Abstract][Full Text] [Related]
19. PEX1 mutations in the Zellweger spectrum of the peroxisome biogenesis disorders.
Crane DI; Maxwell MA; Paton BC
Hum Mutat; 2005 Sep; 26(3):167-75. PubMed ID: 16086329
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]